Calumet (CLMT) to Release Earnings on Friday

Calumet (NASDAQ:CLMTGet Free Report) is projected to release its Q4 2025 results before the market opens on Friday, February 27th. Analysts expect Calumet to post earnings of ($0.67) per share and revenue of $1.0446 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 27, 2026 at 9:00 AM ET.

Calumet Stock Up 0.9%

CLMT opened at $29.25 on Wednesday. Calumet has a 12-month low of $7.68 and a 12-month high of $29.92. The business has a 50 day moving average of $22.50 and a 200-day moving average of $19.68. The stock has a market cap of $2.54 billion, a price-to-earnings ratio of -68.02 and a beta of 1.24.

Wall Street Analyst Weigh In

A number of research firms have commented on CLMT. The Goldman Sachs Group lifted their price objective on shares of Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Weiss Ratings restated a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. Wall Street Zen lowered shares of Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. TD Cowen reissued a “hold” rating on shares of Calumet in a report on Thursday, January 29th. Finally, UBS Group restated a “neutral” rating and set a $26.00 price objective on shares of Calumet in a research report on Friday, February 13th. Four equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $22.83.

Check Out Our Latest Report on CLMT

Institutional Trading of Calumet

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Marshall Wace LLP grew its position in shares of Calumet by 35.8% during the 3rd quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock worth $16,268,000 after purchasing an additional 234,766 shares in the last quarter. Bank of America Corp DE boosted its stake in shares of Calumet by 3.4% in the second quarter. Bank of America Corp DE now owns 609,307 shares of the oil and gas company’s stock valued at $9,600,000 after buying an additional 20,110 shares during the period. Mariner LLC grew its position in Calumet by 959.6% during the third quarter. Mariner LLC now owns 369,408 shares of the oil and gas company’s stock worth $6,742,000 after buying an additional 334,544 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Calumet by 128.3% during the 4th quarter. Goldman Sachs Group Inc. now owns 348,115 shares of the oil and gas company’s stock worth $6,917,000 after acquiring an additional 195,627 shares during the period. Finally, BNP Paribas Financial Markets raised its holdings in Calumet by 3.4% in the 4th quarter. BNP Paribas Financial Markets now owns 290,729 shares of the oil and gas company’s stock valued at $5,777,000 after acquiring an additional 9,605 shares in the last quarter. Institutional investors and hedge funds own 34.41% of the company’s stock.

About Calumet

(Get Free Report)

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.

Recommended Stories

Earnings History for Calumet (NASDAQ:CLMT)

Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.